221 related articles for article (PubMed ID: 1395122)
1. Stimulation of human peripheral blood mononuclear cells with anti-CD3 monoclonal antibody vs IL2: disparate effects on T cell-dependent B cell differentiation despite similar effects on generation of unrestricted cytolytic activity.
Stohl W; Elliott JE
Clin Immunol Immunopathol; 1992 Oct; 65(1):30-8. PubMed ID: 1395122
[TBL] [Abstract][Full Text] [Related]
2. Enhancing effects of interleukin 2-treated peripheral blood mononuclear cells on subsequent B cell differentiation.
Stohl W; Elliott JE; Wang H; Lin YG; Horwitz DA
Cell Immunol; 1994 Sep; 157(2):381-92. PubMed ID: 8069923
[TBL] [Abstract][Full Text] [Related]
3. In vitro inhibition by intravenous immunoglobulin of human T cell-dependent B cell differentiation induced by staphylococcal superantigens.
Stohl W; Elliot JE
Clin Immunol Immunopathol; 1996 May; 79(2):122-33. PubMed ID: 8620618
[TBL] [Abstract][Full Text] [Related]
4. Inhibition by anti-CD2 monoclonal antibodies of anti-CD3-induced T cell-dependent B cell activation.
Stohl W; Crow MK
Cell Immunol; 1990 Oct; 130(2):257-70. PubMed ID: 1976440
[TBL] [Abstract][Full Text] [Related]
5. Induction of suppressor cells to T- and B-cell proliferative responses and immunoglobulin production by monoclonal antibodies recognizing the CD3 T-cell differentiation antigen.
Kunicka JE; Platsoucas CD
Cell Immunol; 1988 Oct; 116(1):195-215. PubMed ID: 2901914
[TBL] [Abstract][Full Text] [Related]
6. The effect of anti-CD3 on the induction of non-MHC restricted cytolytic activity.
Watanabe H; Narumi K; Stewart CC; Arbuck SG; Foon KA; Goldrosen MH
Anticancer Res; 1992; 12(6B):1925-33. PubMed ID: 1295440
[TBL] [Abstract][Full Text] [Related]
7. Major histocompatibility complex-unrestricted cytolytic activity of human T cells. Analysis of precursor frequency and effector phenotype.
Patel SS; Thiele DL; Lipsky PE
J Immunol; 1987 Dec; 139(11):3886-95. PubMed ID: 3500232
[TBL] [Abstract][Full Text] [Related]
8. Impaired generation of polyclonal T cell-mediated cytolytic activity despite normal polyclonal T cell proliferation in systemic lupus erythematosus.
Stohl W
Clin Immunol Immunopathol; 1992 May; 63(2):163-72. PubMed ID: 1611718
[TBL] [Abstract][Full Text] [Related]
9. IL-4 synergizes with IL-10 and anti-CD40 MoAbs to induce B-cell differentiation in patients with common variable immunodeficiency.
Punnonen J; Kainulainen L; Ruuskanen O; Nikoskelainen J; Arvilommi H
Scand J Immunol; 1997 Feb; 45(2):203-12. PubMed ID: 9042433
[TBL] [Abstract][Full Text] [Related]
10. Increased generation of autologous tumor-reactive lymphocytes by anti-CD3 monoclonal antibody and prothymosin alpha.
Baxevanis CN; Spanakos G; Voutsas IF; Gritzapis AD; Tsitsilonis OE; Mamalaki A; Papamichail M
Cancer Immunol Immunother; 1999; 48(2-3):71-84. PubMed ID: 10414460
[TBL] [Abstract][Full Text] [Related]
11. Lipopolysaccharide stimulates the proliferation of human CD56+CD3- NK cells: a regulatory role of monocytes and IL-10.
Goodier MR; Londei M
J Immunol; 2000 Jul; 165(1):139-47. PubMed ID: 10861046
[TBL] [Abstract][Full Text] [Related]
12. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M
Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469
[TBL] [Abstract][Full Text] [Related]
13. The regulation of phenotype and function of human liver CD3+/CD56+ lymphocytes, and cells that also co-express CD8 by IL-2, IL-12 and anti-CD3 monoclonal antibody.
Jin Y; Fuller L; Carreno M; Esquenazi V; Tzakis AG; Miller J
Hum Immunol; 1998 Jun; 59(6):352-62. PubMed ID: 9634197
[TBL] [Abstract][Full Text] [Related]
14. Generation of cytolytic activity with anti-CD3 monoclonal antibodies involves both IL-2-independent and -dependent components.
Stohl W; Tovar Z; Talal N
J Immunol; 1990 May; 144(10):3718-25. PubMed ID: 2139672
[TBL] [Abstract][Full Text] [Related]
15. Injury to autologous normal tissues and tumors mediated by lymphokine-activated killer (LAK) cells generated in vitro from peripheral blood mononuclear cells of glioblastoma patients.
Fujimiya Y; Suzuki Y; Katakura R; Ohno T
J Hematother; 1999 Feb; 8(1):29-37. PubMed ID: 10192299
[TBL] [Abstract][Full Text] [Related]
16. Generation propagation, and targeting of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus recombinant IL-2. An efficient strategy for adoptive tumor immunotherapy.
Nishimura T; Nakamura Y; Takeuchi Y; Tokuda Y; Iwasawa M; Kawasaki A; Okumura K; Habu S
J Immunol; 1992 Jan; 148(1):285-91. PubMed ID: 1345787
[TBL] [Abstract][Full Text] [Related]
17. Generation of CD4+ cytotoxic T lymphocytes stimulated by immobilized anti-CD3 monoclonal antibody and interleukin-2 in cancer patients.
Tani M; Tanimura H; Yamaue H; Mizobata S; Iwahashi M; Tsunoda T; Noguchi K; Tamai M; Hotta T; Terasawa H
Int J Cancer; 1995 Mar; 60(6):802-7. PubMed ID: 7896449
[TBL] [Abstract][Full Text] [Related]
18. Murine anti-CD3 monoclonal antibody induces potent cytolytic activity in both T and NK cell populations.
Stanková J; Hoskin DW; Roder JC
Cell Immunol; 1989 Jun; 121(1):13-29. PubMed ID: 2470516
[TBL] [Abstract][Full Text] [Related]
19. IL-12-mediated activation of MHC-unrestricted cytotoxicity of human PBMC subpopulations: synergic action of a plant rhamnogalacturonan.
Klein-Franke A; Anderer FA
Anticancer Res; 1995; 15(6B):2511-6. PubMed ID: 8669815
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-2-activated murine cell lines with macrophage- and B-lymphoblast-lytic activity.
Suzuki H; Ikemoto M; Yokoyama A; Kamitani T; Yamashita N; Maruyama M; Yano S
Cell Immunol; 1991 Jan; 132(1):127-39. PubMed ID: 1829651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]